Clinical Study

The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation

Table 3

The changes in C3 and C4 parameters of patients.

PatientsC3 (0.9–1.8 g/L)C4 (0.1–0.4 g/L)
Before TCVW4W8Before TCVW4W8

P10.73↓0.68↓0.980.120.110.14
P20.64↓0.950.930.120.210.27
P30.65↓1.31.090.05↓0.250.17
P40.56↓0.980.89↓0.06↓0.110.12
P51.000.911.010.03↓0.09↓0.13
P60.38↓0.80↓0.90.05↓0.160.15
P71.081.041.240.140.180.27
P80.85↓0.69↓0.190.14
P90.64↓0.59↓0.62↓0.07↓0.110.12
P100.62↓0.50↓0.61↓0.09↓0.02↓0.11
P111.021.050.160.19
P120.64↓0.89↓1.190.04↓0.130.21
P130.58↓0.66↓0.910.07↓0.09↓0.11
P141.201.270.250.32
P150.58↓0.84↓0.790.160.190.16
P161.431.380.42↑0.48

value

“—” means data absence.